MTOR and Alzheimer disease: Recent studies from our laboratory and others employing specimens from DS individuals and DS mouse models confirmed that aberrant mTOR signalling is an early degenerating event in the brain that contributes to acceleration of Aβ and tau deposition and to the development of AD-like cognitive decline [7, 9, 13, 21, 22].